02:57 PM EDT, 07/31/2026 (MT Newswires) -- (Updates with recent stock movement in the headline and first paragraph.)

DexCom ( DXCM ) shares rose over 12% in Friday trading, a day after the company posted higher Q2 results and raised its full-year revenue guidance.

The company reported Q2 adjusted earnings late Thursday of $0.70 per diluted share, up from $0.48 a year earlier.

Analysts polled by FactSet expected $0.61.

Revenue for the quarter ended June 30 was $1.31 billion, up from $1.16 billion a year earlier.

Analysts expected $1.29 billion.

For 2026, the company now expects revenue of $5.18 billion to $5.25 billion, up from its prior range of $5.16 billion to $5.25 billion. Analysts expect $5.22 billion.

Price: 83.74, Change: +9.20, Percent Change: +12.34